© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 06, 2017
Patients with hepatitis C genotype 3 may face more liver problems.
January 25, 2017
Hepatitis C reinfection rates appear to be higher within certain populations.
January 18, 2017
Glecaprevir/pibrentasvir had a 99% SVR rate in a Japanese population.
January 13, 2017
The Penn Medicine clinical trial uses kidneys from deceased donors who were infected with the hepatitis C virus. The first person in the trial received a kidney transplant in July and then underwent treatment with a regimen of Zepatier, one of the direct acting antiviral drugs approved recently to treat the virus.
Robert Kushner, MD: An Emphasis on Obesity as CV Risk Factor
Arshad Khanani, MD: Durability of Faricimab for nAMD Based on Two-Year Data
Yasha Modi, MD: Machine Learning Helps Predict Visual Outcomes, Treatment Patterns